|
This guideline on Good Manufacturing
Practices (GMP) pertain to Division 2, Part
C of the Food and Drug Regulations. The
guidelines apply to pharmaceutical,
radiopharmaceutical, biological, and
veterinary drugs and were developed by
Health Canada in consultation with
stakeholders.
These guidelines are designed
to facilitate compliance by the regulated
industry and to enhance consistency in the
application of the regulatory requirements.
Supersedes: 2002 Edition, Version 2
Date issued: May 8, 2009
Date of implementation: November 8, 2009
|
|
|